Cargando…
Experimental Gene Therapy with Serine-Histogranin and Endomorphin 1 for the Treatment of Chronic Neuropathic Pain
The insufficient pain relief provided by current pharmacotherapy for chronic neuropathic pain is a serious medical problem. The enhanced glutamate signaling via NMDA receptors appears to be one of the key events in the development of chronic pain. Although effective, clinical use of systemic NMDA an...
Autores principales: | Jergova, Stanislava, Gordon, Catherine E., Gajavelli, Shyam, Sagen, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727090/ https://www.ncbi.nlm.nih.gov/pubmed/29276474 http://dx.doi.org/10.3389/fnmol.2017.00406 |
Ejemplares similares
-
Viral vectors encoding endomorphins and serine histogranin attenuate neuropathic pain symptoms after spinal cord injury in rats
por: Nasirinezhad, Farinaz, et al.
Publicado: (2015) -
Predifferentiated GABAergic Neural Precursor Transplants for Alleviation of Dysesthetic Central Pain Following Excitotoxic Spinal Cord Injury
por: Lee, Jeung Woon, et al.
Publicado: (2012) -
Selective antinociceptive effects of a combination of the N-methyl-D-aspartate receptor peptide antagonist [Ser(1)]histogranin and morphine in rat models of pain
por: Hama, Aldric, et al.
Publicado: (2014) -
Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model
por: Eeswara, Anjalika, et al.
Publicado: (2023) -
Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain
por: Varamini, Pegah, et al.
Publicado: (2013)